PT110585B - Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização - Google Patents

Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização Download PDF

Info

Publication number
PT110585B
PT110585B PT110585A PT11058518A PT110585B PT 110585 B PT110585 B PT 110585B PT 110585 A PT110585 A PT 110585A PT 11058518 A PT11058518 A PT 11058518A PT 110585 B PT110585 B PT 110585B
Authority
PT
Portugal
Prior art keywords
micro
solution
process according
suspension
solvent
Prior art date
Application number
PT110585A
Other languages
English (en)
Portuguese (pt)
Other versions
PT110585A (pt
Inventor
Temtem Marcio
Vicente João
Sá Couto Clara
Ferreira Rui
Original Assignee
Hovione Farmaciencia Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Farmaciencia Sa filed Critical Hovione Farmaciencia Sa
Priority to PT110585A priority Critical patent/PT110585B/pt
Priority to JP2020544414A priority patent/JP7481259B2/ja
Priority to US16/971,789 priority patent/US11752105B2/en
Priority to AU2019224665A priority patent/AU2019224665B2/en
Priority to KR1020207026942A priority patent/KR102784679B1/ko
Priority to EP19710471.4A priority patent/EP3755307B1/en
Priority to PCT/GB2019/050495 priority patent/WO2019162688A1/en
Priority to CN201980025054.4A priority patent/CN111954520A/zh
Priority to CA3091546A priority patent/CA3091546C/en
Priority to IL276826A priority patent/IL276826B2/en
Publication of PT110585A publication Critical patent/PT110585A/pt
Publication of PT110585B publication Critical patent/PT110585B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0093Microreactors, e.g. miniaturised or microfabricated reactors
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26DRYING
    • F26BDRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00Drying solid materials or objects by processes not involving the application of heat
    • F26B5/005Drying solid materials or objects by processes not involving the application of heat by dipping them into or mixing them with a chemical liquid, e.g. organic; chemical, e.g. organic, dewatering aids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT110585A 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização PT110585B (pt)

Priority Applications (10)

Application Number Priority Date Filing Date Title
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
JP2020544414A JP7481259B2 (ja) 2018-02-22 2019-02-22 スプレー溶液の連続調整を伴うスプレードライプロセス
US16/971,789 US11752105B2 (en) 2018-02-22 2019-02-22 Spray drying process with continuous preparation of spray solution
AU2019224665A AU2019224665B2 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
KR1020207026942A KR102784679B1 (ko) 2018-02-22 2019-02-22 분무 용액의 연속적인 제조를 사용한 분무 건조 방법
EP19710471.4A EP3755307B1 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
PCT/GB2019/050495 WO2019162688A1 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
CN201980025054.4A CN111954520A (zh) 2018-02-22 2019-02-22 连续制备喷雾溶液的喷雾干燥方法
CA3091546A CA3091546C (en) 2018-02-22 2019-02-22 SPRAY DRYING PROCESS WITH CONTINUOUS PREPARATION OF A SPRAY SOLUTION
IL276826A IL276826B2 (en) 2018-02-22 2019-02-22 Spray drying process with continuous preparation of spray solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Publications (2)

Publication Number Publication Date
PT110585A PT110585A (pt) 2019-08-22
PT110585B true PT110585B (pt) 2021-04-22

Family

ID=65729388

Family Applications (1)

Application Number Title Priority Date Filing Date
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Country Status (10)

Country Link
US (1) US11752105B2 (https=)
EP (1) EP3755307B1 (https=)
JP (1) JP7481259B2 (https=)
KR (1) KR102784679B1 (https=)
CN (1) CN111954520A (https=)
AU (1) AU2019224665B2 (https=)
CA (1) CA3091546C (https=)
IL (1) IL276826B2 (https=)
PT (1) PT110585B (https=)
WO (1) WO2019162688A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT110585B (pt) 2018-02-22 2021-04-22 Hovione Farmaciencia Sa Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
US12466883B1 (en) 2024-05-13 2025-11-11 Lumen Bioscience, Inc. Leptin compositions and methods of making and using the same to support weight loss and/or maintenance
WO2026013055A1 (en) 2024-07-09 2026-01-15 Hovione Farmaciência S.A., Methods and systems for preparing feed solutions for spray drying

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5222807A (en) 1991-03-12 1993-06-29 Gaco Manufacturing Division Of Gaddis Petroleum Corporation Low shear polymer dissolution apparatus
FI98892C (fi) 1994-11-15 1997-09-10 Turun Asennusteam Oy Polymeerien liuotusmenetelmä ja -laite
CA2299284C (en) 1997-08-05 2008-07-08 Mfic Corporation Multiple stream high pressure mixer/reactor
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
ZA200905094B (en) * 2006-12-22 2010-09-29 Yuhan Corp Revaprazan-containing solid dispersion and process for the preparation thereof
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
CN105142767B (zh) 2013-03-14 2017-12-12 艺康美国股份有限公司 聚合物溶解系统
KR20160120739A (ko) * 2014-02-11 2016-10-18 램 테라퓨틱스, 인코포레이티드 림프관평활근종증의 치료를 위한 라파마이신
PL3166986T3 (pl) * 2014-07-10 2023-07-31 Huntsman Petrochemical Llc Kompozycja zmniejszająca ilość aldehydów emitowanych z pianek poliuretanowych
PT107846B (pt) * 2014-08-01 2019-03-22 Hovione Farm S A Produção de nano- partículas de dispersões sólidas amorfas por co-precipitação controlada
US9432572B2 (en) * 2014-12-01 2016-08-30 Here Global B.V. Method and apparatus for automatic prediction of dynamic exposure
PT108368B (pt) * 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
PT109117B (pt) * 2016-01-28 2019-02-01 Hovione Farm Sa Complexação de ingredientes ativos farmacêuticos
PT110585B (pt) 2018-02-22 2021-04-22 Hovione Farmaciencia Sa Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Also Published As

Publication number Publication date
CN111954520A (zh) 2020-11-17
WO2019162688A1 (en) 2019-08-29
IL276826B1 (en) 2024-10-01
CA3091546A1 (en) 2019-08-29
EP3755307A1 (en) 2020-12-30
IL276826A (en) 2020-10-29
EP3755307C0 (en) 2023-08-23
KR20200123452A (ko) 2020-10-29
PT110585A (pt) 2019-08-22
EP3755307B1 (en) 2023-08-23
US20210077405A1 (en) 2021-03-18
US11752105B2 (en) 2023-09-12
IL276826B2 (en) 2025-02-01
AU2019224665A1 (en) 2020-11-26
JP2021514954A (ja) 2021-06-17
CA3091546C (en) 2024-11-12
AU2019224665B2 (en) 2024-09-05
JP7481259B2 (ja) 2024-05-10
KR102784679B1 (ko) 2025-03-21

Similar Documents

Publication Publication Date Title
Kumar et al. Particle size reduction techniques of pharmaceutical compounds for the enhancement of their dissolution rate and bioavailability
Esfandiari Production of micro and nano particles of pharmaceutical by supercritical carbon dioxide
Vandana et al. An overview on in situ micronization technique–An emerging novel concept in advanced drug delivery
PT108368B (pt) Produção contínua de partículas
CA2391401C (en) Method for the production of particles
Li et al. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation
Jin et al. Preparation of hydroxypropyl methyl cellulose phthalate nanoparticles with mixed solvent using supercritical antisolvent process and its application in co-precipitation of insulin
Reverchon et al. Supercritical fluids based techniques to process pharmaceutical products difficult to micronize: Palmitoylethanolamide
AU2015353413A1 (en) Amorphous nanoparticles prepared by electrospraying
CN102883798A (zh) 用于制备微粒和纳米粒的方法和设备
Gao et al. Crystallization methods for preparation of nanocrystals for drug delivery system
Kuang et al. Large-scale preparation of amorphous cefixime nanoparticles by antisolvent precipitation in a high-gravity rotating packed bed
PT110585B (pt) Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
Coty et al. Use of Spray Flash Evaporation (SFE) technology to improve dissolution of poorly soluble drugs: Case study on furosemide nanocrystals
JP2021514954A5 (https=)
CN102407028A (zh) 一种连续式超临界流体快速膨胀技术制备聚合物或药物颗粒的方法
ES2964411T3 (es) Un proceso de secado por pulverización con preparación continua de solución de pulverización
Du et al. Supercritical fluid assisted production of chitosan oligomers micrometric powders
Markad et al. Review on: Solubility Enhancement of Poorly Water Soluble Drugs
Zhong et al. Liposomal preparation by supercritical fluids technology
JP2005507773A (ja) 粒子の製造方法
JPWO2019162688A5 (https=)
Mahale et al. Formulation and Characterization of Inclusion Complexes: A Review
KR20070107841A (ko) 디올 화합물을 이용한 나노수준의 활성물질 입자 제조 방법
Mezzomo et al. Supercritical anti-solvent precipitation of sodium ibuprofen

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20190626

FG3A Patent granted, date of granting

Effective date: 20210420